Error: Could not add to watchlist. X
+ Watchlist

NPS Pharmaceuticals Inc

NPSP:US
Acquired
NPSP:US was acquired by SHP:LN
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.08
Market Cap (USD)
-
Shares Outstanding (m)
108.581
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.47%
% Price Change
+0.02%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs.
Address
550 Hills Drive
3rd Floor
Bedminster, NJ 07921
United States
Phone
1-908-450-5300
  • Robin Friedman
    Senior VP:Human Resources
  • Christine Mikail
    Senior VP:Legal Affairs/Gen Cnsl
  • Joseph J Rogus
    VP:Technical Operations
  • Sarah Elton-Farr
    Senior Dir:Investor Relations
Show More